Aug 2026· British Journal of Surgery· Vol 113· 0 citations
TL;DR
Findings support the prognostic relevance of TDs in EOCRC, particularly for metastatic risk, and are associated with an increased risk of distant metastasis in EOCRC but not with overall survival after adjustment.
Abstract
The incidence of early-onset colorectal cancer (EOCRC) is rising. Tumour deposits (TDs) are an independent negative prognostic factor in colorectal cancer (CRC), but their prognostic impact in EOCRC has not been studied. This study aimed to investigate the prognostic effect of TDs on EOCRC patients.
Patients who underwent surgery for CRC between 2011–2014 and 2016–2019 were extracted from the Swedish Colorectal Cancer Registry. Patients were stratified by age (EOCRC (<50 years) versus late-onset CRC (LOCRC, ≥50 years)) and TD status. Kaplan-Meier curves and multivariable Cox regression analyses were used to assess the prognostic effect of TDs in EOCRC patients on overall survival (OS) and distant metastasis (DM) adjusted for sex, number of positive lymph nodes, and neoadjuvant therapy.
Of 26 970 included patients, 12.3% were TD-positive and 4.8% EOCRC. TD-positive EOCRC patients had worse 5-year OS (75.8 versus 92.4%, P < 0.001) and higher 5-year risk of DM (40.6 versus 14.7%, P < 0.001) compared to TD-negative EOCRC patients. In multivariable analysis, TDs were independently associated with increased risk of DM in both EOCRC (HR 1.55, 95% c.i. 1.16–2.07) and LOCRC (HR 1.65, 95% c.i. 1.49–1.84). However, while TD positivity in LOCRC patients was associated with worse OS (HR 1.45, 95% c.i. 1.33–1.58), no independent association with OS was observed for TD-positive EOCRC (HR 0.84, 95% c.i. 0.60–1.18).
TDs are associated with an increased risk of distant metastasis in EOCRC but not with overall survival after adjustment. These findings support the prognostic relevance of TDs in EOCRC, particularly for metastatic risk.
INTRODUCTION
The global rise in early-onset colorectal cancer (EORC) contrasts with declining rates in older adults, suggesting emerging environmental and biological influences. Data from non-Western populations, particularly India, remain scarce despite a young demographic and distinct tumor biology.
METHODS
A retro...
A. Saklani, M. Kazi, Prudvi Raj et al.· European Journal of Surgical...· 0 citations
Brain metastases (BM) from colorectal cancer (CRC) are uncommon but clinically consequential. We characterized clinicomolecular features of CRC patients with BM and evaluated the prognostic impact of BM timing. We screened CRC patients treated/followed between 2015 and 2024 and included those with radiologically confir...
F. Kemik, B. Köylü, C. Kıkılı et al.· Scientific Reports· 0 citations
Background Despite growing awareness of the rising incidence and particular features of early-onset gastrointestinal cancer (EOGIC), evidence from Spain remains limited. The purpose of this study was to compare EOGIC with average-onset gastrointestinal cancer (AOGIC) in Navarre, by analysing incidence trends, clinicopa...
I. Cáseda, A. Huerta, A. Lecumberri et al.· ESMO real world data and dig...· 0 citations
CIPI identifies biologically high-risk stage II CRC with long-term outcomes comparable to stage III disease among patients with normal CA19-9 levels, supporting its role as a complementary prognostic tool beyond conventional pathological staging.
Background Male breast cancer (MBC) represents a rare type of malignant tumor, comprising less than 1% of all breast cancer cases. Therapies for MBC patients are typically adapted from breast cancer treatments in women. This study systematically performed a retrospective evaluation of the clinicopathological features a...
Shi-He Liu, Qi-Ying Song· The Breast Journal· 0 citations
Background: Early-onset breast cancer (EOBC), defined as breast cancer in women under 45 years, is often associated with more aggressive biological behavior and poorer prognosis compared to older patients.
Objectives: (1) To evaluate the clinicopathological, immunohistochemical characteristics, and molecular subtypes...
Phương Thảo Tiên Nguyễn, T. Trần, Anh Hung Tran et al.· Tạp chí Y Dược Huế· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.